世界のうつ病治療装置市場予測（～2028年）：経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他

• 英文タイトル：Global Depression Treatment Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E7780 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

うつ病治療装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のうつ病治療装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 うつ病治療装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界のうつ病治療装置市場の主要な市場プレーヤーは以下のとおりです。 ・Flow Neuroscience AB、Ginger、Electromedical Products International, Inc.、Neuronetics、Alpha-Stim、Fisher Wallace Laboratories、Neurolief、INNOVATIVE NEUROLOGICAL Devices LLC、Magnus Medical、Flow Neuroscience、BrainsWay、Caputron Medical、NeuroStar、The Magstim Company Limited 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、うつ病治療装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なうつ病治療装置メーカーの企業概要、2019年～2022年までのうつ病治療装置の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なうつ病治療装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別うつ病治療装置の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのうつ病治療装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのうつ病治療装置市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびうつ病治療装置の産業チェーンを掲載しています。 ・第13、14、15章では、うつ病治療装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Flow Neuroscience AB、Ginger、Electromedical Products International, Inc.、Neuronetics、Alpha-Stim、Fisher Wallace Laboratories、Neurolief、INNOVATIVE NEUROLOGICAL Devices LLC、Magnus Medical、Flow Neuroscience、BrainsWay、Caputron Medical、NeuroStar、The Magstim Company Limited ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他 ・用途別分析2017年-2028年：病院、クリニック、その他 ・うつ病治療装置の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・うつ病治療装置のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・うつ病治療装置のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・うつ病治療装置の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・うつ病治療装置の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Depression Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Depression Treatment Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Depression Treatment Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transcranial Direct Current Stimulation (tDCS) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Depression Treatment Device include Flow Neuroscience AB, Ginger, Electromedical Products International, Inc., Neuronetics, and Alpha-Stim, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Depression Treatment Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transcranial Direct Current Stimulation (tDCS)
Transcranial Alternating Current Stimulation (tACS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Random Noise Stimulation (tRNS)
Electroconvulsive therapy (ECT)
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Depression Treatment Device market are listed below:
Flow Neuroscience AB
Ginger
Electromedical Products International, Inc.
Neuronetics
Alpha-Stim
Fisher Wallace Laboratories
Neurolief
INNOVATIVE NEUROLOGICAL Devices LLC
Magnus Medical
Flow Neuroscience
BrainsWay
Caputron Medical
NeuroStar
The Magstim Company Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Depression Treatment Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Depression Treatment Device, with price, sales, revenue and global market share of Depression Treatment Device from 2019 to 2022.
Chapter 3, the Depression Treatment Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Depression Treatment Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Depression Treatment Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Depression Treatment Device.
Chapter 13, 14, and 15, to describe Depression Treatment Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Depression Treatment Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Depression Treatment Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Transcranial Direct Current Stimulation (tDCS)
1.2.3 Transcranial Alternating Current Stimulation (tACS)
1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
1.2.5 Transcranial Random Noise Stimulation (tRNS)
1.2.6 Electroconvulsive therapy (ECT)
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Depression Treatment Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Depression Treatment Device Market Size & Forecast
1.4.1 Global Depression Treatment Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Depression Treatment Device Sales in Volume (2017-2028)
1.4.3 Global Depression Treatment Device Price (2017-2028)
1.5 Global Depression Treatment Device Production Capacity Analysis
1.5.1 Global Depression Treatment Device Total Production Capacity (2017-2028)
1.5.2 Global Depression Treatment Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Depression Treatment Device Market Drivers
1.6.2 Depression Treatment Device Market Restraints
1.6.3 Depression Treatment Device Trends Analysis
2 Manufacturers Profiles
2.1 Flow Neuroscience AB
2.1.1 Flow Neuroscience AB Details
2.1.2 Flow Neuroscience AB Major Business
2.1.3 Flow Neuroscience AB Depression Treatment Device Product and Services
2.1.4 Flow Neuroscience AB Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ginger
2.2.1 Ginger Details
2.2.2 Ginger Major Business
2.2.3 Ginger Depression Treatment Device Product and Services
2.2.4 Ginger Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Electromedical Products International, Inc.
2.3.1 Electromedical Products International, Inc. Details
2.3.2 Electromedical Products International, Inc. Major Business
2.3.3 Electromedical Products International, Inc. Depression Treatment Device Product and Services
2.3.4 Electromedical Products International, Inc. Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Neuronetics
2.4.1 Neuronetics Details
2.4.2 Neuronetics Major Business
2.4.3 Neuronetics Depression Treatment Device Product and Services
2.4.4 Neuronetics Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Alpha-Stim
2.5.1 Alpha-Stim Details
2.5.2 Alpha-Stim Major Business
2.5.3 Alpha-Stim Depression Treatment Device Product and Services
2.5.4 Alpha-Stim Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Fisher Wallace Laboratories
2.6.1 Fisher Wallace Laboratories Details
2.6.2 Fisher Wallace Laboratories Major Business
2.6.3 Fisher Wallace Laboratories Depression Treatment Device Product and Services
2.6.4 Fisher Wallace Laboratories Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Neurolief
2.7.1 Neurolief Details
2.7.2 Neurolief Major Business
2.7.3 Neurolief Depression Treatment Device Product and Services
2.7.4 Neurolief Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 INNOVATIVE NEUROLOGICAL Devices LLC
2.8.1 INNOVATIVE NEUROLOGICAL Devices LLC Details
2.8.2 INNOVATIVE NEUROLOGICAL Devices LLC Major Business
2.8.3 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product and Services
2.8.4 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Magnus Medical
2.9.1 Magnus Medical Details
2.9.2 Magnus Medical Major Business
2.9.3 Magnus Medical Depression Treatment Device Product and Services
2.9.4 Magnus Medical Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Flow Neuroscience
2.10.1 Flow Neuroscience Details
2.10.2 Flow Neuroscience Major Business
2.10.3 Flow Neuroscience Depression Treatment Device Product and Services
2.10.4 Flow Neuroscience Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 BrainsWay
2.11.1 BrainsWay Details
2.11.2 BrainsWay Major Business
2.11.3 BrainsWay Depression Treatment Device Product and Services
2.11.4 BrainsWay Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Caputron Medical
2.12.1 Caputron Medical Details
2.12.2 Caputron Medical Major Business
2.12.3 Caputron Medical Depression Treatment Device Product and Services
2.12.4 Caputron Medical Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 NeuroStar
2.13.1 NeuroStar Details
2.13.2 NeuroStar Major Business
2.13.3 NeuroStar Depression Treatment Device Product and Services
2.13.4 NeuroStar Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 The Magstim Company Limited
2.14.1 The Magstim Company Limited Details
2.14.2 The Magstim Company Limited Major Business
2.14.3 The Magstim Company Limited Depression Treatment Device Product and Services
2.14.4 The Magstim Company Limited Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Depression Treatment Device Breakdown Data by Manufacturer
3.1 Global Depression Treatment Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Depression Treatment Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Depression Treatment Device
3.4 Market Concentration Rate
3.4.1 Top 3 Depression Treatment Device Manufacturer Market Share in 2021
3.4.2 Top 6 Depression Treatment Device Manufacturer Market Share in 2021
3.5 Global Depression Treatment Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Depression Treatment Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Depression Treatment Device Market Size by Region
4.1.1 Global Depression Treatment Device Sales in Volume by Region (2017-2028)
4.1.2 Global Depression Treatment Device Revenue by Region (2017-2028)
4.2 North America Depression Treatment Device Revenue (2017-2028)
4.3 Europe Depression Treatment Device Revenue (2017-2028)
4.4 Asia-Pacific Depression Treatment Device Revenue (2017-2028)
4.5 South America Depression Treatment Device Revenue (2017-2028)
4.6 Middle East and Africa Depression Treatment Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Depression Treatment Device Sales in Volume by Type (2017-2028)
5.2 Global Depression Treatment Device Revenue by Type (2017-2028)
5.3 Global Depression Treatment Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Depression Treatment Device Sales in Volume by Application (2017-2028)
6.2 Global Depression Treatment Device Revenue by Application (2017-2028)
6.3 Global Depression Treatment Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Depression Treatment Device Sales by Type (2017-2028)
7.2 North America Depression Treatment Device Sales by Application (2017-2028)
7.3 North America Depression Treatment Device Market Size by Country
7.3.1 North America Depression Treatment Device Sales in Volume by Country (2017-2028)
7.3.2 North America Depression Treatment Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Depression Treatment Device Sales by Type (2017-2028)
8.2 Europe Depression Treatment Device Sales by Application (2017-2028)
8.3 Europe Depression Treatment Device Market Size by Country
8.3.1 Europe Depression Treatment Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Depression Treatment Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Depression Treatment Device Sales by Type (2017-2028)
9.2 Asia-Pacific Depression Treatment Device Sales by Application (2017-2028)
9.3 Asia-Pacific Depression Treatment Device Market Size by Region
9.3.1 Asia-Pacific Depression Treatment Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Depression Treatment Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Depression Treatment Device Sales by Type (2017-2028)
10.2 South America Depression Treatment Device Sales by Application (2017-2028)
10.3 South America Depression Treatment Device Market Size by Country
10.3.1 South America Depression Treatment Device Sales in Volume by Country (2017-2028)
10.3.2 South America Depression Treatment Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Depression Treatment Device Sales by Type (2017-2028)
11.2 Middle East & Africa Depression Treatment Device Sales by Application (2017-2028)
11.3 Middle East & Africa Depression Treatment Device Market Size by Country
11.3.1 Middle East & Africa Depression Treatment Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Depression Treatment Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Depression Treatment Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Depression Treatment Device
12.3 Depression Treatment Device Production Process
12.4 Depression Treatment Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Depression Treatment Device Typical Distributors
13.3 Depression Treatment Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---